US Patent 12,350,256 — assignment history and current owner

US 12,350,256 · Application 17/545,331

Histidine And/or Histidine Derivative For The Treatment Of Inflammatory Skin Diseases

Who owns US Patent 12,350,256?

US12350256 ("Histidine And/or Histidine Derivative For The Treatment Of Inflammatory Skin Diseases") — current assignee: CURAPEL (SCOTLAND) LIMITED. Status: Active, estimated expiration April 5, 2029. 2 recorded USPTO assignments.

Based on recorded USPTO assignment data, the apparent operating assignee of US Patent 12,350,256 is CURAPEL (SCOTLAND) LIMITED. Based on the most recent ownership transfer record (recorded 2021-12-08).

Patent title
Histidine And/or Histidine Derivative For The Treatment Of Inflammatory Skin Diseases
Application number
17/545,331
Apparent operating assignee
CURAPEL (SCOTLAND) LIMITED
Patent status
Active, estimated expiration April 5, 2029
Recorded assignments
2

Recorded assignment history

ExecutedRecordedConveyanceAssignor(s)Assignee(s)Reel/frame
Jun 8, 2009Dec 8, 2021Ownership TransferGIBBS, NEIL KERSLAKETHE UNIVERSITY OF MANCHESTER58338/432
Jun 10, 2014Dec 8, 2021Ownership TransferTHE UNIVERSITY OF MANCHESTERCURAPEL (SCOTLAND) LIMITED58338/468

Scrolls sideways on narrow screens

Chain of title

In 2021, GIBBS, NEIL KERSLAKE assigned the patent to THE UNIVERSITY OF MANCHESTER. The most recent ownership transfer, recorded in 2021, lists CURAPEL (SCOTLAND) LIMITED as assignee.

Apparent recorded rights summary — disclaimer

This tool presents recorded assignment data from the USPTO assignment database. It does not constitute a legal opinion on ownership or title. Assignments may exist that have not been recorded. Corrective records, off-record transfers, court orders, and other events may affect actual ownership. Consult a qualified patent attorney for definitive title analysis.

Ownership settled? Give your AI the file.

Application 17/545,331 · US 12,350,256

The recorded chain of title is one part of the record. PatentReply compiles the rest of US 12,350,256, from the claims as filed to the last action, for Claude, ChatGPT, Grok, or another supported AI client.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Data sourced from public USPTO assignment records. This tool provides informational summaries and should not be relied upon as legal advice or a definitive title opinion. Always verify patent ownership independently, especially where unrecorded transfers, court orders, or other off-record events may apply.